An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma ; volume:3 ; number:1 ; day:23 ; month:12 ; year:2003 ; pages:1-6 ; date:12.2003
BMC infectious diseases ; 3, Heft 1 (23.12.2003), 1-6, 12.2003
- Creator
-
Zhang, Chiyu
- Contributor
-
Chen, Yunyun
Ben, Kunlong
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-3-30
- URN
-
urn:nbn:de:1111-2016030245494
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Chiyu
- Chen, Yunyun
- Ben, Kunlong
- SpringerLink (Online service)
Other Objects (12)
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
Broadly Neutralizing Antibodies for HIV Eradication